Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas S Britt

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Journal of Global Antimicrobial Resistance|June 9, 2016
Clinical epidemiology of vancomycin-resistant <i>Enterococcus gallinarum</i> and <i>Enterococcus casseliflavus</i> bloodstream infectionsNicholas S Britt, Emily M Potter
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 25, 2016
Comparative Effectiveness and Safety of Standard-, Medium-, and High-Dose Daptomycin Strategies for the Treatment of Vancomycin-Resistant Enterococcal Bacteremia Among Veterans Affairs PatientsNicholas S Britt, Emily M Potter, Nimish Patel, et al.
Antibiotics (Basel, Switzerland)|June 28, 2023
Activity of Delafloxacin and Comparator Fluoroquinolones against Multidrug-Resistant <i>Pseudomonas aeruginosa</i> in an In Vitro Cystic Fibrosis Sputum ModelVaughn D Craddock, Evan L Steere, Hannah Harman, et al.
Antimicrobial Agents and Chemotherapy|March 8, 2017
Effect of Continuous and Sequential Therapy among Veterans Receiving Daptomycin or Linezolid for Vancomycin-Resistant Enterococcus faecium BacteremiaNicholas S Britt, Emily M Potter, Nimish Patel, et al.
Antimicrobial Agents and Chemotherapy|March 9, 2016
Vancomycin 24-Hour Area under the Curve/Minimum Bactericidal Concentration Ratio as a Novel Predictor of Mortality in Methicillin-Resistant Staphylococcus aureus BacteremiaNicholas S Britt, Nimish Patel, Rebecca T Horvat, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Reply to Chanderraj et alNicholas S Britt, Emily M Potter, Nimish Patel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 12, 2015
Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs PatientsNicholas S Britt, Emily M Potter, Nimish Patel, et al.
Infectious Diseases and Therapy|December 4, 2014
Tigecycline for the Treatment of Severe and Severe Complicated Clostridium difficile InfectionNicholas S Britt, Molly E Steed, Emily M Potter, et al.
Respiratory Research|July 10, 2020
Extracellular vesicles: novel communicators in lung diseasesAradhana Mohan, Stuti Agarwal, Matthias Clauss, et al.
International Journal of Antimicrobial Agents|January 14, 2020
Activity of pulmonary vancomycin exposures versus planktonic and biofilm isolates of methicillin-resistant Staphylococcus aureus from cystic fibrosis sputumNicholas S Britt, Daniel S Hazlett, Rebecca T Horvat, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Journal of Global Antimicrobial Resistance|June 9, 2016
Clinical epidemiology of vancomycin-resistant <i>Enterococcus gallinarum</i> and <i>Enterococcus casseliflavus</i> bloodstream infectionsNicholas S Britt, Emily M Potter
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 25, 2016
Comparative Effectiveness and Safety of Standard-, Medium-, and High-Dose Daptomycin Strategies for the Treatment of Vancomycin-Resistant Enterococcal Bacteremia Among Veterans Affairs PatientsNicholas S Britt, Emily M Potter, Nimish Patel, et al.
Antibiotics (Basel, Switzerland)|June 28, 2023
Activity of Delafloxacin and Comparator Fluoroquinolones against Multidrug-Resistant <i>Pseudomonas aeruginosa</i> in an In Vitro Cystic Fibrosis Sputum ModelVaughn D Craddock, Evan L Steere, Hannah Harman, et al.
Antimicrobial Agents and Chemotherapy|March 8, 2017
Effect of Continuous and Sequential Therapy among Veterans Receiving Daptomycin or Linezolid for Vancomycin-Resistant Enterococcus faecium BacteremiaNicholas S Britt, Emily M Potter, Nimish Patel, et al.
Antimicrobial Agents and Chemotherapy|March 9, 2016
Vancomycin 24-Hour Area under the Curve/Minimum Bactericidal Concentration Ratio as a Novel Predictor of Mortality in Methicillin-Resistant Staphylococcus aureus BacteremiaNicholas S Britt, Nimish Patel, Rebecca T Horvat, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Reply to Chanderraj et alNicholas S Britt, Emily M Potter, Nimish Patel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 12, 2015
Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs PatientsNicholas S Britt, Emily M Potter, Nimish Patel, et al.
Infectious Diseases and Therapy|December 4, 2014
Tigecycline for the Treatment of Severe and Severe Complicated Clostridium difficile InfectionNicholas S Britt, Molly E Steed, Emily M Potter, et al.
Respiratory Research|July 10, 2020
Extracellular vesicles: novel communicators in lung diseasesAradhana Mohan, Stuti Agarwal, Matthias Clauss, et al.
International Journal of Antimicrobial Agents|January 14, 2020
Activity of pulmonary vancomycin exposures versus planktonic and biofilm isolates of methicillin-resistant Staphylococcus aureus from cystic fibrosis sputumNicholas S Britt, Daniel S Hazlett, Rebecca T Horvat, et al.
Pageof 3